Hytrin
Hytrin Price range: $ 57,00 through $ 451,00
Back to products
I-Pill
I-Pill Price range: $ 40,00 through $ 135,00

Hyzaar

Price range: $ 25,00 through $ 470,00

Hyzaar is a highly effective combination medication specifically formulated to manage hypertension and support long-term cardiovascular health. It integrates two active ingredients, losartan and hydrochlorothiazide, to lower high blood pressure through multiple clinical mechanisms. The losartan component helps relax and widen blood vessels, while the diuretic hydrochlorothiazide assists the body in eliminating excess salt and water. This medication is also officially indicated to reduce the risk of stroke in patients diagnosed with high blood pressure and left ventricular hypertrophy. By consistently maintaining healthy blood pressure levels, Hyzaar helps protect vital organs and reduces the overall workload on the heart.

Active substance: hydroclorotiazide, Losartan
SKU: Hyzaar Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Hyzaar belongs to a group of combination cardiovascular medications containing an angiotensin II receptor blocker and a thiazide diuretic. It is prescribed for the management of hypertension and to reduce stroke risk in patients with high blood pressure and left ventricular hypertrophy.

Available exclusively as a prescription medication under FDA regulatory standards, this dual-component therapy helps regulate blood pressure by targeting distinct physiological pathways. Proper clinical monitoring is essential during treatment to evaluate renal function and electrolyte equilibrium.

Property Details
Drug name Hyzaar
Active ingredient (INN) Losartan potassium / Hydrochlorothiazide
Therapeutic class Angiotensin II receptor antagonist and thiazide diuretic combination
Dosage form Oral tablet
Route of administration Oral
Primary purpose Antihypertensive therapy and cardiovascular risk reduction
Prescription status Prescription (Rx) only
Storage Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F)

Clinical Overview and Administration

How the drug works

Hyzaar combines two active components with complementary mechanisms of action: losartan potassium and hydrochlorothiazide. Losartan is a selective, competitive angiotensin II receptor antagonist that specifically blocks the AT1 receptor subtype. By preventing angiotensin II from binding to these receptors in vascular smooth muscle and the adrenal gland, losartan inhibits vasoconstriction and aldosterone secretion. This mechanism lowers peripheral vascular resistance without significantly altering cardiac heart rate.

Hydrochlorothiazide is a thiazide diuretic that acts directly on the distal renal convoluted tubule. It inhibits the reabsorption of sodium and chloride ions, promoting their excretion along with water. This increase in diuresis leads to a reduction in plasma volume and cardiac output. The combined administration of an angiotensin II receptor antagonist and a thiazide diuretic provides an additive blood pressure-lowering effect compared to either agent administered alone.

Main uses

Hyzaar is indicated for two primary clinical scenarios approved by regulatory authorities. First, it is used for the treatment of hypertension in patients whose blood pressure is not adequately controlled with losartan or hydrochlorothiazide monotherapy. Controlling elevated blood pressure reduces the overall risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

Second, Hyzaar is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (LVH). Evidence indicates that this benefit may not apply equally to Black patients due to underlying demographic variations in hypertensive pathophysiology, a consideration clinicians evaluate when selecting antihypertensive regimens.

Dosing schedule

Hyzaar is administered orally once daily, with or without food. Available fixed-dose combinations include 50 mg/12.5 mg, 100 mg/12.5 mg, and 100 mg/25 mg of losartan potassium and hydrochlorothiazide, respectively. Dosing must be individualized based on blood pressure response and clinical objectives. Patients transitioning from monotherapy typically begin with the 50 mg/12.5 mg tablet.

The maximum recommended dose is 100 mg/25 mg once daily. Full therapeutic effects are generally observed within three to four weeks after initiating or titrating therapy. Dosage adjustments should be guided by a licensed healthcare provider following routine clinical evaluations.

What happens in the body

Following oral administration, losartan potassium is rapidly absorbed and undergoes significant first-pass hepatic metabolism via cytochrome P450 enzymes (CYP2C9 and CYP3A4). This metabolic process yields an active carboxylic acid metabolite, designated E-3174, which is substantially more potent than losartan itself. Systemic bioavailability of losartan is approximately 33%. Peak plasma concentrations of losartan and E-3174 occur at approximately 1 hour and 3 to 4 hours, respectively. The terminal elimination half-life of losartan is about 2 hours, whereas that of E-3174 ranges from 6 to 9 hours.

Hydrochlorothiazide is absorbed efficiently from the gastrointestinal tract with an oral bioavailability between 60% and 80%. It is not metabolized in the liver and is eliminated primarily unchanged by the kidneys via glomerular filtration and active tubular secretion. The plasma half-life of hydrochlorothiazide ranges between 5.6 and 14.8 hours. Renal impairment prolongs the elimination half-life of hydrochlorothiazide, requiring careful monitoring.

Compatibility with other medicines

Hyzaar exhibits several clinically significant drug-drug interactions requiring dosage adjustment or careful monitoring. Concomitant administration with potassium supplements, potassium-sparing diuretics (such as spironolactone, triamterene, or amiloride), or salt substitutes containing potassium elevates the risk of severe hyperkalemia. Simultaneous use with nonsteroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors, may attenuate the antihypertensive effect and increase the risk of renal function deterioration, particularly in elderly or volume-depleted patients.

Thiazide diuretics can reduce renal clearance of lithium, leading to increased serum lithium concentration and potential toxicity. Co-administration of dual renin-angiotensin system inhibitors (such as combining Hyzaar with ACE inhibitors or aliskiren) is generally avoided due to heightened risks of hypotension, hyperkalemia, and acute renal failure.

Adverse reactions

Clinical trials and post-marketing surveillance report that Hyzaar is generally well tolerated, though adverse effects can occur. Common adverse reactions include upper respiratory tract infections, dizziness, lightheadedness, and fatigue. Due to the diuretic component, serum electrolyte disturbances such as hypokalemia, hyperkalemia, hyponatremia, and hypercalcemia may develop.

Less frequently, patients may experience orthostatic hypotension, back pain, muscle cramps, or gastrointestinal disturbances such as nausea and diarrhea. Rare but serious reactions include hypersensitivity reactions, angioedema (swelling of the face, lips, throat, or tongue), systemic vasculitis, severe renal insufficiency, and blood dyscrasias like agranulocytosis. Patients experiencing signs of a severe allergic reaction or a sudden reduction in urine output require prompt medical attention.

Important Warnings and Safety Information

Before you take it

Hyzaar carries a Boxed Warning regarding fetal toxicity. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus when administered during the second and third trimesters of pregnancy. When pregnancy is detected, Hyzaar must be discontinued as soon as possible.

This medication is contraindicated in patients with anuria or known hypersensitivity to losartan, hydrochlorothiazide, or other sulfonamide-derived drugs. Extreme caution is required in patients with severe renal impairment, hepatic impairment, renal artery stenosis, or severe volume depletion. Regular laboratory monitoring of serum electrolytes (potassium, sodium, magnesium), blood urea nitrogen (BUN), and serum creatinine is mandatory during long-term therapy.

Food and alcohol interactions

Hyzaar may be taken with or without food, as food intake does not produce clinically meaningful changes in the absorption of either losartan or hydrochlorothiazide. However, patients should avoid heavy alcohol consumption while taking Hyzaar. Alcohol potentiates the blood pressure-lowering effect of the medication, which increases the likelihood of orthostatic hypotension, dizziness, and fainting.

Care should also be exercised regarding dietary potassium intake. Because losartan can increase serum potassium levels, high intake of potassium-rich foods or potassium-containing salt substitutes should be discussed with a physician before adoption.

Missed dose

If a dose of Hyzaar is missed, it should be taken as soon as remembered on the same day. However, if it is almost time for the next scheduled dose, the missed tablet should be skipped, and the regular dosing schedule resumed. Double doses should never be taken to make up for a missed tablet, as this increases the risk of symptomatic hypotension and severe electrolyte imbalances.

How to tell if it’s working

High blood pressure typically presents without noticeable symptoms, meaning patients rarely feel when Hyzaar is working. Therapeutic effectiveness is determined by objective blood pressure measurements taken at home or in a clinical setting. Progressive reduction in systolic and diastolic blood pressure reading is usually evident within one to two weeks, with the full therapeutic effect expected after three to four weeks of continuous daily administration.

Storage and expiration

Hyzaar tablets should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). The container must be kept tightly closed, protected from light, moisture, and excessive heat. Do not store the medication in humid areas such as bathrooms. Always keep out of reach of children and pets. Do not use tablets past the expiration date printed on the original packaging.

Frequently Asked Questions

Can Hyzaar be stopped abruptly if blood pressure normalizes?

No, antihypertensive therapy should not be discontinued suddenly without medical advice. Discontinuing Hyzaar abruptly can result in a rebound spike in blood pressure, exposing the patient to increased cardiovascular risk. Blood pressure control requires ongoing management even when readings return to target levels.

Does Hyzaar increase skin sensitivity to sunlight?

Yes, hydrochlorothiazide, the thiazide diuretic component of Hyzaar, can cause photosensitivity in some individuals. Patients taking Hyzaar may burn more easily in natural sunlight or tanning beds. Using sunscreen, wearing protective clothing, and limiting direct sun exposure during peak hours are recommended preventative measures.

How often are blood tests required while taking Hyzaar?

Periodic blood tests are necessary to evaluate kidney function and monitor serum potassium, sodium, and uric acid levels. These tests are typically conducted before starting treatment, a few weeks after initiation or dose adjustments, and periodically during maintenance therapy as determined by the prescribing provider.

Is it safe to operate machinery or drive after taking Hyzaar?

Caution is advised, especially during the initial weeks of treatment or following a dose increase. Hyzaar can cause dizziness or lightheadedness due to blood pressure reduction. Patients should determine how they react to the medication before driving, operating heavy machinery, or engaging in tasks requiring alertness.

This content is informational and does not replace a consultation with your doctor or pharmacist. In accordance with FDA requirements.

Additional information
Dosage

12.5mg+12.5mg

,

25mg+12.5mg

,

50mg+12.5mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία

,